Clinical Trial

Evaluation of the Efficacy of Phospholipid-Bound Omega-3 Versus Omega-3 Alone in Patients With Hypertriglyceridemia: A Randomized Clinical Trial

Study acronym: OMEGA-PHYT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Hypertriglyceridemia is a significant risk factor for cardiovascular diseases. Omega-3 fatty acids have been shown to reduce triglyceride levels, and their combination with phospholipids could offer additional benefits in improving lipid profiles and inflammatory markers. This study aims to evaluate the efficacy of combining omega-3 with phospholipids compared to omega-3 alone in patients with hypertriglyceridemia. The objective of the clinical trial is to provide robust evidence on the benefits of this combination in improving lipid profiles and reducing inflammation, which could have a significant impact on clinical practices and future dietary recommendations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-19.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-07-14
Trial Details
NCT Number NCT06749028
Lead Sponsor Fundación del Caribe para la Investigación Biomédica
Collaborators: Naturmega
Conditions Hypertriglyceridemia
Enrollment 44 participants
Start Date 2024-12-17
Primary Completion 2025-05-20 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-17